Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Aleph Therapeutics Inc
Profile last edited on: 10/25/2021      CAGE: 7PR95      UEI: PH2KFR4TMT84

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2016
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

915 Cottrell Way
Stanford, CA 94305
   N/A
   N/A
   N/A
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

Aleph Therapeutics develops a vaccine for Acute Flaccid Myelitis, a neurological disease with polio-like symptoms. The major curative agent, EV-D68, is an airborne respiratory virus making it difficult to prevent transmission and there has yet to be an antiviral treatment developed for AFM.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$550,215
Phase II Dollars
$295,928
Total Awarded
$846,143

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
0
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 2 NIH $595,928
Project Title: Targeting Covid-19 with a Therapeutic Interfering Particle
2020 1 NIH $250,215
Project Title: A Vaccine for Acute Flaccid Myelitis

Key People / Management

  Raul Andino

Company News

There are no news available.